The Association between Telomere Length and Cancer Prognosis: Evidence from a Meta-Analysis

• Published in: PloS one 2015-07, Vol.10 (7), p.e0133174-e0133174
• Main Authors: Zhang, Chunli, Chen, Xiaohua, Li, Lu, Zhou, Ying, Wang, Chao, Hou, Shuxun
• Format: Article
• Language: English
• Subjects: Aging; Analysis; Breast cancer; Cancer; Cancer genetics; Cell cycle; Cell survival; Chromosomes; Chronic lymphocytic leukemia; Colorectal cancer; Colorectal carcinoma; Confidence intervals; Deoxyribonucleic acid; Development and progression; Disease; Disease Progression; DNA; Esophagus; Health aspects; Health risks; Hospitals; Humans; Laboratories; Leukemia; Lymphatic leukemia; Medical prognosis; Melanoma; Meta-analysis; Mortality; Mutation; Neoplasms - diagnosis; Neoplasms - pathology; Orthopedics; Populations; Predictions; Prognosis; Publication Bias; Risk assessment; Skin cancer; Southern blotting; Stability analysis; Studies; Survival; Survival Analysis; Systematic review; Telomerase; Telomere Homeostasis; Telomeres
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0133174

Telomeres are essential for chromosomal integrity and stability. Shortened telomere length (TL) has been associated with risk of cancers and aging-related diseases. Several studies have explored associations between TL and cancer prognosis, but the results are conflicting. Prospective studies on the relationship between TL and cancer survival were identified by a search of PubMed up to May 25, 2015. There were no restrictions on the cancer type or DNA source. The quality of the included studies was assessed using the Newcastle-Ottawa Scale. Meta-analysis approaches were conducted to determine pooled relative risks and 95% confidence intervals. Thirty-three articles containing forty-five independent studies were ultimately involved in our meta-analysis, of which twenty-seven were about overall cancer survival and eighteen were about cancer progression. Short TL was associated with increased cancer mortality risk (RR = 1.30, 95%CI: 1.06-1.59) and poor cancer progression (RR = 1.44, 95%CI: 1.10-1.88), both with high levels of heterogeneity (I2 = 83.5%, P = 0.012for overall survival and I2 = 75.4%, P = 0.008 for progression). TL was an independent predictor of overall cancer survival and progression in chronic lymphocytic leukemia. Besides, short telomeres were also associated with increased colorectal cancer mortality and decreased overall survival of esophageal cancer, but not in other cancers. Cancer progression was associated with TL in Asian and America populations and short TL predicted poor cancer survival in older populations. Compared with tumor tissue cells, TL in blood lymphocyte cells was better for prediction. In addition, the associations remained significant when restricted to studies with adjustments for age, with larger sample sizes, measuring TL using southern blotting or estimating risk effects by hazard ratios. Short TL demonstrated a significant association with poor cancer survival, suggesting the potential prognostic significance of TL. Additional large well-designed studies are needed to confirm our findings.